Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Cme Group Inc.

CME · Nasdaq · Security & Commodity Brokers, Dealers, Exchanges & Services

Fundamental quality

ATTRACTIVE

82

out of 100

Breakdown by area

I.GrowthEPS: 15.2% · Revenue: 9.6%
67
II.ProfitabilityNet margin: 63.2% · ROE: 16%
85
III.Financial healthNet debt/EBITDA: -0.53x · FCF: 64.1%
95

Source: SEC EDGAR · TTM through 31/03/2026

Reading the numbers

On average over recent years, earnings per share grew 15.2% a year and revenue advanced 9.6% a year.

On profitability, Cme Group Inc. shows a net margin of 63.2%, an ROE of 16%.

Its financial health shows net debt of -0.53 times its EBITDA and a free cash flow margin of 64.1%.

Adding up growth, profitability and financial strength, the traffic light gives CME a fundamental quality of 82 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Cme Group Inc. cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Cme Group Inc.?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →